VMD (Viemed Healthcare) ROCE %: 10.92% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VMD Viemed Healthcare Inc VMD
93 GF Score
Price $12.11
GF Value $10.94
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Viemed Healthcare ROCE %?

Viemed Healthcare VMD 93 ROCE % is 10.92% as of Mar. 2026. GuruFocus rates VMD with a GF Score™ of 93/100 and a GF Value™ of $10.94 (Fairly Valued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Viemed Healthcare's annualized ROCE % for the quarter that ended in Mar. 2026 was 10.92%.

Viemed Healthcare  (NAS:VMD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Viemed Healthcare ROCE % Related Terms

Viemed Healthcare ROCE % Historical Data

* Premium members only.

The historical data trend for Viemed Healthcare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viemed Healthcare ROCE % Chart

Viemed Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.52 9.26 13.41 12.91 15.41

Viemed Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.88 12.30 14.77 21.17 10.92
VMD
93GF Score
Viemed Healthcare Inc VMD
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viemed Healthcare ROCE % Calculation

Viemed Healthcare's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=22.949/( ( (177.069 - 37.326) + (199.154 - 41.056) )/ 2 )
=22.949/( (139.743+158.098)/ 2 )
=22.949/148.9205
=15.41 %

Viemed Healthcare's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=17.184/( ( (199.154 - 41.056) + (197.361 - 40.706) )/ 2 )
=17.184/( ( 158.098 + 156.655 )/ 2 )
=17.184/157.3765
=10.92 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 10.92% mean?
Viemed Healthcare (VMD) has a ROCE % of 10.92% as of Mar. 2026.
Is Viemed Healthcare's ROCE % too high?
Viemed Healthcare's current ROCE % is 10.92%. The Medical Devices & Instruments industry median ROCE % is 2.26. Viemed Healthcare's value of 10.92% is 383.2% above this industry median. Overall, Viemed Healthcare has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's ROCE % compare to DCTH and VREX?
Viemed Healthcare's ROCE % of 10.92% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.26. Viemed Healthcare's value of 10.92% is 383.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.26, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viemed Healthcare's current ROCE % of 10.92% is 383.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viemed Healthcare's current ROCE % is 10.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (VMD) is currently considered Fairly Valued. The stock's GF Value™ is $10.94, compared to a current price of $12.11 — trading 10.7% above its estimated fair value. The current ROCE % is 10.92% and 383.2% above the Medical Devices & Instruments industry median of 2.26. Viemed Healthcare's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Viemed Healthcare (VMD), the current ROCE % is 10.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viemed Healthcare (VMD) Overvalued in 2026?

Based on GuruFocus' analysis, Viemed Healthcare stock appears to be overvalued. The current stock price of $12.11 is trading 10.7% above its estimated GF Value™ of $10.94. GuruFocus considers Viemed Healthcare to be Fairly Valued.

Key valuation signals for VMD:

  • ROCE %: 10.92%
  • GF Value™: $10.94 vs. price of $12.11 (10.7% above fair value)
  • GF Score™: 93/100 with 7 warning signs
  • Industry Position: 383.2% above the Medical Devices & Instruments median

No single metric tells the full story. See the VMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Viemed Healthcare Business Description

Other Exchanges VIJ:Germany
Address 625 E. Kaliste Saloom Road, Lafayette, LA, USA, 70508
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
93GF Score

Get the complete analysis for VMD

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.11
Price
$10.94
GF Value